# Alimera Sciences Inc. (ALIM)

Source: https://www.quantisnow.com/company/ALIM
Generated: 2026-11-03T19:19:54.497Z

- Ticker: ALIM
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2010
- Website: alimerasciences.com

## About

Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of prescription ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and could lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.

## Latest ALIM news and filings

- 2024-09-26 20:55 UTC [SEC Form 15-12G filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-alimera-sciences-inc-5706219)
- 2024-09-23 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-alimera-sciences-inc-5701400)
- 2024-09-23 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-alimera-sciences-inc-5701399)
- 2024-09-19 01:54 UTC [SEC Form 4] [SEC Form 4 filed by Chief Financial Officer Maltz Elliot](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-financial-officer-maltz-elliot-5698822)
- 2024-09-19 01:53 UTC [SEC Form 4] [SEC Form 4 filed by Director Kaseta Michael](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-kaseta-michael-5698821)
- 2024-09-19 01:53 UTC [SEC Form 4] [Chief Marketing Officer & SVP Holland David returned 187,756 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/chief-marketing-officer-svp-holland-david-returned-187756-shares-to-5698820)
- 2024-09-19 01:53 UTC [SEC Form 4] [Director Snisarenko John returned 10,000 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-snisarenko-john-returned-10000-shares-to-the-company-closing-5698819)
- 2024-09-19 01:53 UTC [SEC Form 4] [President and CEO Eiswirth Richard S Jr returned 324,018 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/president-and-ceo-eiswirth-richard-s-jr-returned-324018-shares-5698818)
- 2024-09-19 01:53 UTC [SEC Form 4] [SEC Form 4 filed by Director Pax Margaret](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-pax-margaret-5698817)
- 2024-09-19 01:53 UTC [SEC Form 4] [Director Pizzo Peter J. Iii returned 500 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-pizzo-peter-j-iii-returned-500-shares-to-the-5698816)
- 2024-09-19 01:53 UTC [SEC Form 4] [SEC Form 4 filed by President of U.S. Operations Wood Todd Michael](https://www.quantisnow.com/insight/sec-form-4-filed-by-president-of-us-operations-wood-5698815)
- 2024-09-19 01:52 UTC [SEC Form 4] [SEC Form 4 filed by Director Parsons Erin](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-parsons-erin-5698814)
- 2024-09-19 01:52 UTC [SEC Form 4] [SEC Form 4 filed by Director Demont Ross D](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-demont-ross-d-5698813)
- 2024-09-19 01:52 UTC [SEC Form 4] [Chief Operating Officer Werner Jason M. returned 225,000 shares to the company, decreasing direct ownership by 50% to 225,000 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-operating-officer-werner-jason-m-returned-225000-shares-to-5698812)
- 2024-09-19 01:51 UTC [SEC Form 4] [President of Int'l Operations Ashman Philip returned 118,274 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/president-of-intl-operations-ashman-philip-returned-118274-shares-to-5698811)
- 2024-09-18 20:30 UTC [SEC Form 4] [Large owner Caligan Partners Lp disposed of 16,835,154 shares (SEC Form 4)](https://www.quantisnow.com/insight/large-owner-caligan-partners-lp-disposed-of-16835154-shares-sec-5698335)
- 2024-09-18 20:30 UTC [SEC Schedule 13D] [Amendment: SEC Form SC 13D/A filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13da-filed-by-alimera-sciences-inc-5698327)
- 2024-09-16 21:13 UTC [SEC Form 4] [Director Morgan Adam returned 13,608,533 shares to the company (SEC Form 4)](https://www.quantisnow.com/insight/director-morgan-adam-returned-13608533-shares-to-the-company-sec-5695450)
- 2024-09-16 21:10 UTC [SEC Schedule 13D] [Amendment: SEC Form SC 13D/A filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-13da-filed-by-alimera-sciences-inc-5695430)
- 2024-09-16 20:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alimera-sciences-inc-5695151)
- 2024-09-16 20:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alimera-sciences-inc-5695149)
- 2024-09-16 20:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alimera-sciences-inc-5695148)
- 2024-09-16 20:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alimera-sciences-inc-5695147)
- 2024-09-16 20:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alimera-sciences-inc-5695146)
- 2024-09-16 20:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alimera-sciences-inc-5695145)
- 2024-09-16 20:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alimera-sciences-inc-5695144)
- 2024-09-16 20:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alimera-sciences-inc-5695143)
- 2024-09-16 20:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alimera-sciences-inc-5695142)
- 2024-09-16 20:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alimera-sciences-inc-5695141)
- 2024-09-16 20:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alimera-sciences-inc-5695140)
- 2024-09-16 20:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alimera-sciences-inc-5695139)
- 2024-09-16 20:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alimera-sciences-inc-5695138)
- 2024-09-16 20:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alimera-sciences-inc-5695137)
- 2024-09-16 20:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alimera-sciences-inc-5695136)
- 2024-09-16 20:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alimera-sciences-inc-5695135)
- 2024-09-16 20:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alimera-sciences-inc-5695134)
- 2024-09-16 20:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alimera-sciences-inc-5695133)
- 2024-09-16 20:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-alimera-sciences-inc-5695132)
- 2024-09-16 20:15 UTC [SEC Form POS AM filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-alimera-sciences-inc-5695083)
- 2024-09-16 20:14 UTC [SEC Form POS AM filed by Alimera Sciences Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-alimera-sciences-inc-5695053)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ALIM
- Earnings history: https://www.quantisnow.com/earnings/ALIM
- Dividend history: https://www.quantisnow.com/dividends/ALIM
- Insider transactions: https://www.quantisnow.com/insiders/ALIM
- Options chain: https://www.quantisnow.com/options/ALIM
- SEC 8-K filings only: https://www.quantisnow.com/company/ALIM/8-k
- RSS and alerts for ALIM: https://www.quantisnow.com/docs/rss-feeds.md